139 related articles for article (PubMed ID: 23290632)
1. A decline in the prevalence of injecting drug users in Estonia, 2005-2009.
Uusküla A; Rajaleid K; Talu A; Abel-Ollo K; Des Jarlais DC
Int J Drug Policy; 2013 Jul; 24(4):312-8. PubMed ID: 23290632
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of injecting drug use in Estonia 2010-2015: a capture-recapture study.
Raag M; Vorobjov S; Uusküla A
Harm Reduct J; 2019 Mar; 16(1):19. PubMed ID: 30871554
[TBL] [Abstract][Full Text] [Related]
3. Risk for Heterosexual HIV Transmission Among Non-Injecting Female Partners of Injection Drug Users in Estonia.
Uusküla A; McMahon JM; Kals M; Talu A; Abel-Ollo K; Rüütel K; Des Jarlais DC
AIDS Behav; 2013 Mar; 17(3):879-88. PubMed ID: 22038080
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of injecting drug use in a Russian city: implications for harm reduction and coverage.
Platt L; Hickman M; Rhodes T; Mikhailova L; Karavashkin V; Vlasov A; Tilling K; Hope V; Khutorksoy M; Renton A
Addiction; 2004 Nov; 99(11):1430-8. PubMed ID: 15500596
[TBL] [Abstract][Full Text] [Related]
5. Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002.
Brady JE; Friedman SR; Cooper HL; Flom PL; Tempalski B; Gostnell K
J Urban Health; 2008 May; 85(3):323-51. PubMed ID: 18344002
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of IGRA-positivity and risk factors for tuberculosis among injecting drug users in Estonia and Latvia.
Rüütel K; Karnite A; Talu A; Abel-Ollo K; Kirvelaite G; Kliiman K; Loit HM; Uusküla A
Int J Drug Policy; 2014 Jan; 25(1):175-8. PubMed ID: 24210296
[TBL] [Abstract][Full Text] [Related]
7. Capture--recapture and anchored prevalence estimation of injecting drug users in England: national and regional estimates.
Hay G; Gannon M; MacDougall J; Eastwood C; Williams K; Millar T
Stat Methods Med Res; 2009 Aug; 18(4):323-39. PubMed ID: 19036919
[TBL] [Abstract][Full Text] [Related]
8. High-prevalence and high-estimated incidence of HIV infection among new injecting drug users in Estonia: need for large scale prevention programs.
Uusküla A; Kals M; Rajaleid K; Abel K; Talu A; Rüütel K; Platt L; Rhodes T; Dehovitz J; Des Jarlais D
J Public Health (Oxf); 2008 Jun; 30(2):119-25. PubMed ID: 18308743
[TBL] [Abstract][Full Text] [Related]
9. Estonia at the threshold of the fourth decade of the AIDS era in Europe.
Laisaar KT; Avi R; DeHovitz J; Uusküla A
AIDS Res Hum Retroviruses; 2011 Aug; 27(8):841-51. PubMed ID: 21142588
[TBL] [Abstract][Full Text] [Related]
10. Estimating the size and dynamics of an injecting drug user population and implications for health service coverage: comparison of indirect prevalence estimation methods.
Kimber J; Hickman M; Degenhardt L; Coulson T; van Beek I
Addiction; 2008 Oct; 103(10):1604-13. PubMed ID: 18638037
[TBL] [Abstract][Full Text] [Related]
11. The role of injection drug use in the emergence of Human Immunodeficiency Virus infection in Estonia.
Uusküla A; Kalikova A; Zilmer K; Tammai L; DeHovitz J
Int J Infect Dis; 2002 Mar; 6(1):23-7. PubMed ID: 12044297
[TBL] [Abstract][Full Text] [Related]
12. HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.
Talu A; Rajaleid K; Abel-Ollo K; Rüütel K; Rahu M; Rhodes T; Platt L; Bobrova N; Uusküla A
Int J Drug Policy; 2010 Jan; 21(1):56-63. PubMed ID: 19395249
[TBL] [Abstract][Full Text] [Related]
13. Estimation of injecting drug users in the City of Edinburgh, Scotland, and number infected with human immunodeficiency virus.
Davies AG; Cormack RM; Richardson AM
Int J Epidemiol; 1999 Feb; 28(1):117-21. PubMed ID: 10195675
[TBL] [Abstract][Full Text] [Related]
14. Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia.
Platt L; Wall M; Rhodes T; Judd A; Hickman M; Johnston LG; Renton A; Bobrova N; Sarang A
J Urban Health; 2006 Nov; 83(6 Suppl):i39-53. PubMed ID: 17096189
[TBL] [Abstract][Full Text] [Related]
15. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
16. Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe.
Jõgeda EL; Avi R; Pauskar M; Kallas E; Karki T; Des Jarlais D; Uusküla A; Lutsar I; Huik K
Infect Genet Evol; 2016 Sep; 43():83-5. PubMed ID: 27223634
[TBL] [Abstract][Full Text] [Related]
17. Estimating prevalence of injecting drug use: a comparison of multiplier and capture-recapture methods in cities in England and Russia.
Hickman M; Hope V; Platt L; Higgins V; Bellis M; Rhodes T; Taylor C; Tilling K
Drug Alcohol Rev; 2006 Mar; 25(2):131-40. PubMed ID: 16627302
[TBL] [Abstract][Full Text] [Related]
18. Emergent properties of HIV risk among injection drug users in Tallinn, Estonia: synthesis of individual and neighbourhood-level factors.
Uusküla A; McMahon JM; Raag M; Silm S; Rüütel K; Talu A; Abel-Ollo K; Ahas R; Des Jarlais DC
Sex Transm Infect; 2010 Dec; 86 Suppl 3():iii79-84. PubMed ID: 21098060
[TBL] [Abstract][Full Text] [Related]
19. Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis.
Tavitian-Exley I; Boily MC; Heimer R; Uusküla A; Levina O; Maheu-Giroux M
AIDS Behav; 2018 Apr; 22(4):1329-1340. PubMed ID: 28699018
[TBL] [Abstract][Full Text] [Related]
20. Condom use and partnership intimacy among drug injectors and their sexual partners in Estonia.
Uusküla A; Abel-Ollo K; Markina A; McNutt LA; Heimer R
Sex Transm Infect; 2012 Feb; 88(1):58-62. PubMed ID: 22056984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
